1. Home
  2. INDP vs ASTI Comparison

INDP vs ASTI Comparison

Compare INDP & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • ASTI
  • Stock Information
  • Founded
  • INDP 2000
  • ASTI 2005
  • Country
  • INDP United States
  • ASTI United States
  • Employees
  • INDP N/A
  • ASTI N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • INDP Health Care
  • ASTI Technology
  • Exchange
  • INDP Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • INDP 6.0M
  • ASTI 6.7M
  • IPO Year
  • INDP N/A
  • ASTI N/A
  • Fundamental
  • Price
  • INDP $3.87
  • ASTI $2.31
  • Analyst Decision
  • INDP Strong Buy
  • ASTI
  • Analyst Count
  • INDP 2
  • ASTI 0
  • Target Price
  • INDP $238.00
  • ASTI N/A
  • AVG Volume (30 Days)
  • INDP 1.4M
  • ASTI 206.4K
  • Earning Date
  • INDP 11-11-2025
  • ASTI 11-13-2025
  • Dividend Yield
  • INDP N/A
  • ASTI N/A
  • EPS Growth
  • INDP N/A
  • ASTI N/A
  • EPS
  • INDP N/A
  • ASTI N/A
  • Revenue
  • INDP N/A
  • ASTI $41,135.00
  • Revenue This Year
  • INDP N/A
  • ASTI N/A
  • Revenue Next Year
  • INDP N/A
  • ASTI N/A
  • P/E Ratio
  • INDP N/A
  • ASTI N/A
  • Revenue Growth
  • INDP N/A
  • ASTI N/A
  • 52 Week Low
  • INDP $2.22
  • ASTI $1.10
  • 52 Week High
  • INDP $58.24
  • ASTI $4.41
  • Technical
  • Relative Strength Index (RSI)
  • INDP 50.07
  • ASTI 55.14
  • Support Level
  • INDP $3.35
  • ASTI $2.12
  • Resistance Level
  • INDP $4.00
  • ASTI $2.53
  • Average True Range (ATR)
  • INDP 0.77
  • ASTI 0.21
  • MACD
  • INDP 0.12
  • ASTI -0.00
  • Stochastic Oscillator
  • INDP 42.15
  • ASTI 68.15

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: